Stay updated with breaking news from Gen Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study from the University of Michigan Health Rogel Cancer Center reveals a connection between the most common type of white blood cells, which act as a first defense in the body's immune system, and a severe complication of CAR T-Cell immunotherapy.
It is the first in-person meeting at this level between the two sides in 18 months. Read more at straitstimes.com.
Global cancer trial investigator sites have increased 50% in just five years but led to a rise in the number of poorly performing sites, new research ha...
Clinical trial sites for cancer are proliferating, but a lack of investigators with experience in trial recruitment is weighing on their performance.
Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis